For the quarter ending 2026-03-31, CDXS made $15,248K in revenue. -$8,704K in net income. Net profit margin of -57.08%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenues | 15,248 | 38,915 | 8,601 | 15,328 |
| Cost of product revenue | 2,064 | 2,043 | 2,465 | 2,098 |
| Research and development | 11,448 | 11,722 | 13,868 | 13,775 |
| Selling, general and administrative | 9,779 | 11,185 | 11,217 | 12,317 |
| Restructuring charges | - | 3,407* | - | - |
| Asset impairment and other charges | - | 0* | 0 | 0 |
| Total costs and operating expenses | 23,291 | 28,357 | 27,550 | 28,190 |
| Gain from operations | -8,043 | 10,558 | -18,949 | -12,862 |
| Interest income | 665 | 656 | 634 | 584 |
| Interest and other expense, net | -1,290 | -1,595 | -1,292 | -984 |
| Gain before income taxes | -8,668 | 9,619 | -19,607 | -13,262 |
| Provision for income taxes | 36 | 18 | 8 | 10 |
| Net gain | -8,704 | 9,601 | -19,615 | -13,272 |
| Basic EPS | -0.1 | 0.106 | -0.22 | -0.16 |
| Diluted EPS | -0.1 | 0.106 | -0.22 | -0.16 |
| Basic Average Shares | 90,768,000 | 90,518,000 | 90,251,000 | 85,389,000 |
| Diluted Average Shares | 90,768,000 | 90,518,000 | 90,251,000 | 85,389,000 |